Abstract
Purpose :
Lysosomes are recognized as a major store of intracellular Ca2+, and lysosomal Ca2+ signaling is implicated in exocytosis, vesicle fusion, and transcriptional control of autophagy. The TRPML1 cation channel is a major conduit for lysosomal Ca2+ efflux and its activity can be compromised by lysosomal lipid accumulation. The lysosomes of RPE cells process the shed tips of photoreceptor outer segments and their own autophagic material, and undegraded material can accumulate as lipofuscin. RPE cells from the ABCA4-/- mouse model of Stargardt’s disease are characterized by large deposit of lipofuscin. Here we asked whether lysosomal Ca2+ signaling in the ABCA4-/- mouse was defective
Methods :
Mice were treated in accordance with ARVO guidelines. Ca2+ levels from isolated RPE cells were determined by Ca2+ imaging with dye fura-2; cellular lipofuscin did not affect the dye signal. TRPML1 mRNA was quantified by qPCR. Total lysosomal Ca2+ was determined from levels released into the cytoplasm following lysosomal rupture by glycyl-L-phenylalanine-beta-naphthylamide (GPN).
Results :
The TRPML1 Ca2+ channel was expressed in mouse RPE cells. Stimulation of RPE cells from control mice with channel agonist MLSA1 induced a robust rise in cytoplasmic Ca2+. This Ca2+ rise was not dependent on extracellular Ca2+ or disrupted by thapsigargin, consistent with its lysosomal source. RPE cells from TRPML1-/- mice did not respond to MLSA1, confirming receptor identification. Finally, ABCA4-/- RPE cells were stimulated with MLSA1 and Ca2+ release was decreased by 85% compared to control RPE cells. TRPML1 expression did not differ between RPE cells from control and ABCA4-/- mice. Total lysosomal Ca2+ were the same in RPE cells from control and ABCA4-/- mice, as determined with GPN
Conclusions :
The release of Ca2+ from lysosomes in mouse RPE cells is substantial, and is mediated, at least in part, by the TRPML1 channel. The impaired release of lysosomal Ca2+ in RPE cells of the ABCA4-/- mouse may reflect impaired channel activity, as TRPML1 expression and lysosomal Ca2+ levels were unchanged. Whether this impaired lysosomal signaling contributes to the pathology in Stargardt’s remains to be determined
This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.